Strata Skin Sciences Outlines Growth and Profitability Plans

An update from Strata Skin Sciences ( (SSKN) ) is now available.

STRATA Skin Sciences has posted an investor presentation highlighting its strategic initiatives to drive growth in the dermatology market. The company plans to enhance its recurring revenue model through a direct-to-consumer marketing strategy to increase device usage and return to positive cash flow, while also expanding its international sales operations. The company reported a slight decrease in total revenue for the third quarter of 2024 compared to the previous year, but achieved a positive operating profit for the first time since 2018, indicating improved financial performance.

More about Strata Skin Sciences

STRATA Skin Sciences is a medical technology company that provides advanced in-office medical devices for treating dermatological conditions such as psoriasis, vitiligo, eczema, and acne. The company operates in a $38 billion market and is recognized globally for its dermatology procedures, with a focus on delivering effective solutions in partnership with clinics.

YTD Price Performance: -45.45%

Average Trading Volume: 11,481

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $12.51M

For detailed information about SSKN stock, go to TipRanks’ Stock Analysis page.